Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
SCTID: 1157107003, Defined, Active
1157107003|Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)|
- en Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
- en Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
- en Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination
- en 2019-ncov non-replicating viral vector immunisation
- en 2019-ncov non-replicating viral vector immunization
- en 2019-ncov non-replicating viral vector vaccination
- en 2019 novel coronavirus non-replicating viral vector immunisation
- en 2019 novel coronavirus non-replicating viral vector immunization
- en 2019 novel coronavirus non-replicating viral vector vaccination
- en Administration of sars-cov-2 non-replicating viral vector vaccine
- en Covid-19 non-replicating viral vector immunisation
- en Covid-19 non-replicating viral vector immunization
- en Covid-19 non-replicating viral vector vaccination
- en Sars-cov-2 non-replicating viral vector immunisation
- en Sars-cov-2 non-replicating viral vector immunization
- en Sars-cov-2 non-replicating viral vector vaccination